14 business development director specialty testing central labs jobs found

Labcorp is seeking a field-based Business Development Director, Specialty Testing for our Central Labs! Job Responsibilities: Be responsible for selling highly scientific Translational Biomarker and Diagnostic Services to targeted accounts. Engage external and internal stakeholders on a range of scientific testing services in the area of biomarkers, anatomic pathology and histology, flow cytometry, vaccine services, genomic testing and companion diagnostics. Participate in proposal scope development as appropriate. Establish, nurture and grow client relationships at the appropriate levels. Achieve annual sales plan and sales targets for assigned accounts through proactive sales activity and networking with assigned potential and existing accounts. Develop account plans and strategies to gain business in assigned accounts in collaboration and partnership with other Labcorp team members. Develop client call cycle to achieve objectives and sales plan;...

Labcorp is seeking a field-based Business Development Director, Specialty Testing for our Central Labs! Job Responsibilities: Be responsible for selling highly scientific Translational Biomarker and Diagnostic Services to targeted accounts. Engage external and internal stakeholders on a range of scientific testing services in the area of biomarkers, anatomic pathology and histology, flow cytometry, vaccine services, genomic testing and companion diagnostics. Participate in proposal scope development as appropriate. Establish, nurture and grow client relationships at the appropriate levels. Achieve annual sales plan and sales targets for assigned accounts through proactive sales activity and networking with assigned potential and existing accounts. Develop account plans and strategies to gain business in assigned accounts in collaboration and partnership with other Labcorp team members. Develop client call cycle to achieve objectives and sales plan;...

Labcorp is seeking a field-based Business Development Director, Specialty Testing for our Central Labs! Job Responsibilities: Be responsible for selling highly scientific Translational Biomarker and Diagnostic Services to targeted accounts. Engage external and internal stakeholders on a range of scientific testing services in the area of biomarkers, anatomic pathology and histology, flow cytometry, vaccine services, genomic testing and companion diagnostics. Participate in proposal scope development as appropriate. Establish, nurture and grow client relationships at the appropriate levels. Achieve annual sales plan and sales targets for assigned accounts through proactive sales activity and networking with assigned potential and existing accounts. Develop account plans and strategies to gain business in assigned accounts in collaboration and partnership with other Labcorp team members. Develop client call cycle to achieve objectives and sales plan;...

Labcorp is seeking a field-based Business Development Director, Specialty Testing for our Central Labs! Job Responsibilities: Be responsible for selling highly scientific Translational Biomarker and Diagnostic Services to targeted accounts. Engage external and internal stakeholders on a range of scientific testing services in the area of biomarkers, anatomic pathology and histology, flow cytometry, vaccine services, genomic testing and companion diagnostics. Participate in proposal scope development as appropriate. Establish, nurture and grow client relationships at the appropriate levels. Achieve annual sales plan and sales targets for assigned accounts through proactive sales activity and networking with assigned potential and existing accounts. Develop account plans and strategies to gain business in assigned accounts in collaboration and partnership with other Labcorp team members. Develop client call cycle to achieve objectives and sales plan;...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration....

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Role Summary: The Health Systems Regional Scientific Director (HSRSD) is a therapeutic and disease expert who develops on-going professional relationships with healthcare decision makers within defined regional payer organizations (e.g., health plans, PBMs, integrated delivery systems (IDN), large GI practices, specialty pharmacy and other key health systems in the...

The Associate Director, Precision Medicine Clinical Laboratory Operations will be responsible for Clinical Laboratory Project & Program management for various therapeutic areas working closely with Director, Precision Medicine Clinical Laboratory Operations and key cross-functional collaborators. The primary role will be to provide strategic oversight of laboratory deliverables across the portfolio, ensuring that study start timelines are met , provide risk management. Collaborates with stakeholders for all aspects of clinical laboratory deliverables (from study conduct, sample management testing to launch). This will be done in collaboration with Precision Medicine Strategy Leads, Clinical Trial Management, Clinical Laboratory Operations Management, Global Development colleagues and central and specialty testing laboratories to support early and late-stage programs within our pipeline.   As an Associate Director, a typical day may include the following:...

Job Description: JOB SUMMARY : The Kerr Regional Sales Director, Eastern Canada will be responsible for the strategic development and management of an assigned region that sells company-manufactured products through designated distributors/dealers. This position will establish and implement the overall sales strategy in Eastern Canada to meet the growth objectives of the business and achieve maximum results. Develops, presents, implements, and manages strategic sales efforts, to meet sales plans and forecasts. PRIMARY DUTIES & RESPONSIBILITIES : Recognizes and capitalizes on all go-to-market opportunities, for profitability and business growth. Builds a strong direct sales team, and develops talent through coaching, feedback, and support. Develops a clear vision and direction for the future of the business or the organization.  Develops effective relationships with Marketing to drive marketing strategies and priorities. Maintains existing and develops new...